# Ligusticum wallichii

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/ligusticum-wallichii
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 6 / 10
**Category:** Traditional Chinese Medicine
**Also Known As:** Ligusticum wallichii, Chuanxiong, Szechuan lovage, Chinese lovage, Cnidium officinale, Chuan xiong, Ligusticum striatum

## Overview

Ligusticum wallichii is a traditional Chinese medicinal herb containing tetramethylpyrazine as its primary bioactive compound. It works by improving blood circulation through vasodilation and antiplatelet aggregation mechanisms.

## Health Benefits

• Cerebrovascular protection: One RCT (n=158) showed 89.2% effectiveness rate for transient ischemic attack treatment versus 61.7% with aspirin (moderate evidence)
• [Cardiovascular](/ingredients/condition/heart-health) support: Preclinical studies demonstrate improved left ventricular ejection fraction and reduced infarct size post-myocardial infarction (preliminary evidence)
• [Anti-inflammatory](/ingredients/condition/inflammation) effects: Extract inhibits IL-1β expression via TLR4-NF-κB signaling pathway in cardiac tissue (preliminary evidence)
• Bronchial health: Animal studies showed inhibition of bronchospasm and reduced TXB2 levels (P < 0.01) (preliminary evidence)
• Blood circulation enhancement: Traditional use supported by network pharmacology identifying EGFR, STAT3, and SRC as core targets (traditional/preliminary evidence)

## Mechanism of Action

Ligusticum wallichii's primary bioactive compound tetramethylpyrazine inhibits platelet aggregation by blocking calcium channels and reducing thromboxane A2 production. The herb promotes vasodilation through nitric oxide pathway activation and antagonizes vasoconstriction mediated by endothelin-1. Additional phthalide compounds enhance microcirculation by improving red blood cell deformability and reducing blood viscosity.

## Clinical Summary

One randomized controlled trial with 158 participants demonstrated Ligusticum wallichii's 89.2% effectiveness rate for treating transient ischemic attacks, significantly outperforming aspirin's 61.7% rate. Preclinical studies show [cardiovascular](/ingredients/condition/heart-health) benefits including improved left ventricular ejection fraction and reduced myocardial infarct size. However, human clinical evidence remains limited with most research conducted in animal models. The available evidence suggests moderate support for cerebrovascular applications but requires larger clinical trials for definitive therapeutic recommendations.

## Nutritional Profile

Ligusticum wallichii (Chuanxiong) rhizome contains negligible macronutrients in therapeutic dosing (typically 3–9g dried herb or 1–2g extract). Primary bioactive compounds include: tetramethylpyrazine (ligustrazine) at approximately 0.1–0.5% dry weight — the principal vasoactive alkaloid; ferulic acid at 0.02–0.05% dry weight — a phenolic acid with [antioxidant](/ingredients/condition/antioxidant) and antiplatelet activity; senkyunolide A and Z-ligustilide (phthalide lactones) comprising roughly 1–5% of volatile oil fraction; and cnidilide and butylidenephthalide as additional phthalides. Polysaccharide content ranges 5–8% dry weight contributing mild [immunomodulatory](/ingredients/condition/immune-support) activity. Calcium, potassium, and magnesium are present in trace mineral amounts typical of root herbs but are not clinically significant contributors. Bioavailability note: tetramethylpyrazine demonstrates rapid oral absorption (Tmax ~1 hour) but short half-life (~2–3 hours), necessitating divided dosing; ferulic acid bioavailability is enhanced in aqueous decoctions versus raw powder; Z-ligustilide is volatile and degrades with prolonged high-heat processing.

## Dosage & Preparation

Clinical dosing poorly defined; preclinical studies used aqueous extract at 0.2-0.6 g/kg body weight daily in rats, while isolated ligustrazine was studied at >150 mg/kg daily for kidney protection. Human standardized extract dosages not established in available research. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Ligusticum wallichii may increase bleeding risk when combined with anticoagulant medications like warfarin or antiplatelet drugs due to its blood-thinning properties. Common side effects include mild gastrointestinal upset, dizziness, and headache in sensitive individuals. The herb should be avoided during pregnancy and breastfeeding due to insufficient safety data. Patients scheduled for surgery should discontinue use at least two weeks prior to prevent excessive bleeding complications.

## Scientific Research

Limited human clinical evidence exists, with one RCT (PMID: 1301850) treating 158 patients with transient ischemic attack showing superiority of Ligusticum wallichii over aspirin. Most evidence comes from preclinical studies, including rat myocardial infarction models (PMC4150451) and bronchial asthma research (PMID: 7841753), with no large-scale RCTs or meta-analyses identified.

## Historical & Cultural Context

Ligusticum wallichii has been used in Traditional Chinese Medicine for over 1,000 years to invigorate blood circulation, relieve pain, and treat [cardiovascular](/ingredients/condition/heart-health) conditions. Historically applied in TCM formulas for headache, menstrual issues, and vascular protection.

## Synergistic Combinations

Ligusticum wallichii pairs strongly with Danshen (Salvia miltiorrhiza), where tanshinones and salvianolic acids complement tetramethylpyrazine's vasodilatory effects through additive nitric oxide pathway activation and synergistic inhibition of platelet aggregation via both COX and thromboxane A2 suppression — this combination is the basis of the commercial formulation Danshen Dripping Pills. Pairing with Astragalus membranaceus (Huangqi) is supported by preclinical data showing that astragaloside IV and cycloastragenol enhance tetramethylpyrazine's cardioprotective effects by upregulating HIF-1α and improving microcirculation, with the combination demonstrating greater reduction in myocardial infarct size than either alone in rodent models. Ferulic acid's bioavailability and [anti-inflammatory](/ingredients/condition/inflammation) synergy is amplified when combined with Angelica sinensis (Dang Gui), which shares ferulic acid as a constituent and whose Z-butylidenephthalide acts on complementary smooth [muscle relaxation](/ingredients/condition/sleep) pathways — this pairing is classical in Traditional Chinese Medicine's 'Siwu Tang' formula and has preliminary clinical evidence for hematological and cerebrovascular applications.

## Frequently Asked Questions

### What is the active compound in Ligusticum wallichii?

The primary active compound is tetramethylpyrazine, which provides antiplatelet and vasodilatory effects. Other bioactive components include phthalides like ligustilide and senkyunolide that enhance circulation.

### How effective is Ligusticum wallichii for stroke prevention?

One clinical trial showed 89.2% effectiveness for transient ischemic attacks compared to 61.7% with aspirin. However, more large-scale human studies are needed to confirm stroke prevention benefits.

### What is the typical dosage of Ligusticum wallichii?

Traditional Chinese medicine typically uses 3-10 grams of dried root daily in decoctions. Standardized extracts may require different dosing, so consultation with a qualified practitioner is recommended.

### Can Ligusticum wallichii interact with blood thinners?

Yes, it can significantly increase bleeding risk when combined with warfarin, aspirin, or other anticoagulants due to its antiplatelet effects. Medical supervision is essential for concurrent use.

### Is Ligusticum wallichii safe during pregnancy?

No, it should be avoided during pregnancy and breastfeeding due to insufficient safety data and potential effects on blood circulation. Consult healthcare providers before use in reproductive-age women.

### What does the research show about Ligusticum wallichii's effectiveness for transient ischemic attacks?

A randomized controlled trial with 158 participants demonstrated that Ligusticum wallichii achieved a 89.2% effectiveness rate for treating transient ischemic attacks, compared to 61.7% with aspirin alone, suggesting superior outcomes for this cerebrovascular condition. This moderate-quality evidence indicates the herb may offer meaningful benefits for patients experiencing temporary stroke-like symptoms. However, more large-scale studies are needed to confirm these findings and establish optimal protocols for clinical use.

### Who benefits most from taking Ligusticum wallichii supplements?

Individuals with a history of cerebrovascular events, including transient ischemic attacks or those seeking cardiovascular support, may benefit most from Ligusticum wallichii supplementation based on current research. People concerned with cardiovascular health following myocardial infarction may also find value, though preclinical evidence for this application remains preliminary. Those with inflammatory conditions related to vascular dysfunction could potentially benefit from its anti-inflammatory properties, though clinical confirmation is still ongoing.

### How does Ligusticum wallichii work to protect blood vessels and the brain?

Ligusticum wallichii appears to work through multiple mechanisms, including inhibition of inflammatory markers like IL-1β, which reduces vascular inflammation and protects cerebrovascular tissue. Preclinical studies show it improves left ventricular function and reduces cardiac damage, suggesting effects on both blood vessel and heart tissue. These combined anti-inflammatory and cardioprotective actions may explain its traditional use in Chinese herbal medicine for stroke prevention and cerebral ischemia.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*